129 related articles for article (PubMed ID: 11825324)
41. Mitogenic potency of insulin glargine.
Zełobowska K; Gumprecht J; Grzeszczak W
Endokrynol Pol; 2009; 60(1):34-9. PubMed ID: 19224503
[TBL] [Abstract][Full Text] [Related]
42. Nocturnal glucose metabolism after bedtime injection of insulin glargine or neutral protamine hagedorn insulin in patients with type 2 diabetes.
Linn T; Fischer B; Soydan N; Eckhard M; Ehl J; Kunz C; Bretzel RG
J Clin Endocrinol Metab; 2008 Oct; 93(10):3839-46. PubMed ID: 18611975
[TBL] [Abstract][Full Text] [Related]
43. Injection of acidic or neutral insulin and pain: a single-center, prospective, controlled, noninterventional study in pediatric patients with type 1 diabetes mellitus.
Karges B; Muche R; Riegger I; Moritz M; Heinze E; Debatin KM; Wabitsch M; Karges W
Clin Ther; 2006 Dec; 28(12):2094-101. PubMed ID: 17296465
[TBL] [Abstract][Full Text] [Related]
44. Plasma glucose and hypoglycaemia following exercise in people with Type 1 diabetes: a comparison of three basal insulins.
Arutchelvam V; Heise T; Dellweg S; Elbroend B; Minns I; Home PD
Diabet Med; 2009 Oct; 26(10):1027-32. PubMed ID: 19900235
[TBL] [Abstract][Full Text] [Related]
45. [Insulin analogues: searching for a physiological replacement].
Eyzaguirre F; Codner E
Rev Med Chil; 2006 Feb; 134(2):239-50. PubMed ID: 16554934
[TBL] [Abstract][Full Text] [Related]
46. A review of modern insulin analogue pharmacokinetic and pharmacodynamic profiles in type 2 diabetes: improvements and limitations.
Evans M; Schumm-Draeger PM; Vora J; King AB
Diabetes Obes Metab; 2011 Aug; 13(8):677-84. PubMed ID: 21410860
[TBL] [Abstract][Full Text] [Related]
47. Insulin glargine controversy: a tribute to the editorial team at Diabetologia.
Butler PC
Diabetes; 2009 Nov; 58(11):2427-8. PubMed ID: 19875618
[No Abstract] [Full Text] [Related]
48. Diabetes treatment with insulin glargine and risk of malignancy: methodological pitfalls and ethical issues.
Simon D
Diabetologia; 2010 Jan; 53(1):204-5. PubMed ID: 19859691
[No Abstract] [Full Text] [Related]
49. Insulin glargine and incidence of cancer--an ongoing debate.
Hermanns N; Kulzer B
J Diabetes Sci Technol; 2010 Mar; 4(2):497-8. PubMed ID: 20307414
[No Abstract] [Full Text] [Related]
50. [The role of insulin analogues in the current treatment of diabetes mellitus].
Mitrović M; Pantelinac P; Radosavljević J; Bajkin I; Todorović-Dilas L
Med Pregl; 2006; 59(11-12):539-44. PubMed ID: 17633894
[TBL] [Abstract][Full Text] [Related]
51. Insulin analogues in the management of the pregnancy complicated by diabetes mellitus.
Durnwald CP; Landon MB
Curr Diab Rep; 2011 Feb; 11(1):28-34. PubMed ID: 21072620
[TBL] [Abstract][Full Text] [Related]
52. Update on insulin analogues.
Drug Ther Bull; 2004 Oct; 42(10):77-80. PubMed ID: 15491022
[TBL] [Abstract][Full Text] [Related]
53. Evaluation of the carcinogenic potential of insulin glargine (LANTUS) in rats and mice.
Stammberger I; Bube A; Durchfeld-Meyer B; Donaubauer H; Troschau G
Int J Toxicol; 2002; 21(3):171-9. PubMed ID: 12055018
[TBL] [Abstract][Full Text] [Related]
54. [Insulin analogs: structure, properties and therapeutic indication. Part 2. Long-acting insulin analogs].
Rosak C
Internist (Berl); 2001 Dec; 42(12):1692-9. PubMed ID: 11793609
[No Abstract] [Full Text] [Related]
55. Efficacy and Cardiovascular Safety of Insulins.
Fernandez CJ; Radhakrishnan C
Curr Drug Saf; 2021; 16(2):217-232. PubMed ID: 33153425
[TBL] [Abstract][Full Text] [Related]
56. Insulin glargine use during pregnancy.
Pantalone KM; Faiman C; Olansky L
Endocr Pract; 2011; 17(3):448-55. PubMed ID: 21613047
[TBL] [Abstract][Full Text] [Related]
57. Mitogenic action of insulin: friend, foe or 'frenemy'?
Draznin B
Diabetologia; 2010 Feb; 53(2):229-33. PubMed ID: 19851749
[TBL] [Abstract][Full Text] [Related]
58. A lesson in early morning hyperglycemia.
Harmon C; Willoughby DF; Floyd C
Nurse Pract; 2004 Nov; 29(11):58-63. PubMed ID: 15625495
[No Abstract] [Full Text] [Related]
59. The insulin glargine dilemma: an opportunity for the diabetes community?
Stumvoll M; Nawroth PP
Diabetologia; 2009 Oct; 52(10):1987-9. PubMed ID: 19680625
[No Abstract] [Full Text] [Related]
60. Differences in metabolic and mitogenic signallingof insulin glargine and AspB10 human insulin in rats [corrected].
Tennagels N; Welte S; Hofmann M; Brenk P; Schmidt R; Werner U
Diabetologia; 2013 Aug; 56(8):1826-34. PubMed ID: 23653049
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
